Home › Pancreatic Cancer › Vermont
Pancreatic Cancer clinical trials in Vermont
3 studies for Pancreatic Cancer are looking for participants at sites in Vermont.
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Dartmouth Cancer Center - North, Saint Johnsbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.